slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2.055 KRW | +2,75% | +10,07% | +13,04% |
Grafiek agenda Enzychem Lifesciences Corporation
Komende gebeurtenissen op Enzychem Lifesciences Corporation
Gebeurtenissen op naam
14-11-2023 | Q3 2023 Cijferpublicaties |
14-08-2023 | Q2 2023 Cijferpublicaties |
15-05-2023 | Q1 2023 Cijferpublicaties |
21-03-2023 | Q4 2022 Cijferpublicaties |
16-08-2022 | Eerste halfjaar 2022 Cijferpublicaties |
24-06-2022 | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology Me |
16-05-2022 | Q1 2022 Cijferpublicaties |
17-08-2021 | Eerste halfjaar 2021 Cijferpublicaties |
10-06-2021 | BIO International Conference |
24-05-2021 20:30 | Keystone Virtual Scientific Conference |
17-05-2021 | Q1 2021 Cijferpublicaties |
23-03-2021 | Boekjaar 2020 Cijferpublicaties |
16-03-2021 17:00 | New York Health Forum - Panel |
14-03-2021 03:00 | NASH-TAG Conference |
30-03-2020 | Boekjaar 2019 Cijferpublicaties |
15-01-2020 00:30 | Biotech Showcase |
11-11-2019 14:00 | American Association for the Study of Liver Diseases Meeting |
29-10-2019 17:30 | AACR-NCI-EORTC International Conference - Abstract Number: C037 |
28-10-2019 17:30 | AACR-NCI-EORTC International Conference - Abstract Number: B054 |
27-10-2019 17:30 | AACR-NCI-EORTC International Conference - Abstract: A070 |
Gebeurtenissen in het verleden in de sector Enzychem Lifesciences Corporation
03-05-2024 12:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Cijferpublicaties |
03-05-2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Cijferpublicaties (schatting) |
03-05-2024 | AARTI DRUGS LIMITED: Q4 2024 Cijferpublicaties |
03-05-2024 | DEVA HOLDING: Q1 2024 Cijferpublicaties (schatting) |
02-05-2024 22:01 | AMGEN INC.: Q1 2024 Cijferpublicaties |
02-05-2024 19:43 | ALK-ABELLÓ A/S: Q1 2024 Cijferpublicaties |
02-05-2024 13:30 | ORGANON & CO.: Q1 2024 Cijferpublicaties |
02-05-2024 13:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Cijferpublicaties |
02-05-2024 07:30 | NOVO NORDISK A/S: Q1 2024 Cijferpublicaties |
02-05-2024 | GC BIOPHARMA CORP.: Q1 2024 Cijferpublicaties |
- Beurs
- Aandelen
- Koers A183490
- Agenda Enzychem Lifesciences Corporation